Courtyard Of Natchitoches Medicare and Medicaid Location: 708 Keyser Avenue, Natchitoches, Louisiana 71457 Ratings: Phone: (318) 214-4361 |
Natchitoches Nursing And Rehabilitation Center,llc Medicare and Medicaid Location: 750 Keyser Avenue, Natchitoches, Louisiana 71457 Ratings: Phone: (318) 352-8779 |
Natchitoches Community Care Center Medicare and Medicaid Location: 720 Keyser Avenue, Natchitoches, Louisiana 71457 Ratings: Phone: (318) 352-8296 |
News Archive
When Congress passed the health law in 2010, it also banned the Internal Revenue Service from using its regular enforcement techniques.
Today, 20 states and the National Federation of Independent Business are planning "to file their response to the government's attempt to dismiss their lawsuit challenging President Barack Obama's health care overhaul. The Justice Department in June asked a federal judge to dismiss the lawsuit, saying the U.S. District Court in Pensacola lacks subject-matter jurisdiction over some of the lawsuit's claims. ... A key issue raised by their lawsuit is whether the federal government can require individuals to purchase health care insurance and fine those who don't" (Kay, 8/6).
The New York Times: A judicial ruling that "threw out parts of two gene patents and called into question thousands more" has biotechnology executives hastening "to reassure their investors that the ruling would not necessarily undermine their businesses, at least in the short run. But the executives themselves were struggling on Tuesday to figure out what the long-term impact would be."
A team led by Massimo Squatrito, Head of the Seve Ballesteros Foundation Brain Tumour Group at the Spanish National Cancer Research Centre, have made important findings of how some gliomas can acquire chemoresistance.
This has been a good week for breakthroughs in HIV/AIDS. Earlier this week, the Food and Drug Administration approved a daily pill, Truvada, which reduces the risk of HIV infection. Today, a University of Nebraska Medical Center research team's progress toward developing weekly or twice-monthly injectable antiretroviral therapy (ART) nanomedicines for patients with human immunodeficiency virus (HIV) infection will be highlighted as the cover story in the Journal of Infectious Diseases.
› Verified 2 days ago